文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

人类免疫缺陷病毒感染者中的严重细菌性非艾滋病感染:ANRS CO3 AquiVih-Nouvelle-Aquitaine 队列 2000-2017 年 18 年间抗生素耐药性的流行病学与演变

Severe Bacterial Non-AIDS Infections in Persons With Human Immunodeficiency Virus: The Epidemiology and Evolution of Antibiotic Resistance Over an 18-Year Period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine Cohort.
PubMed 文献 · Clin Infect Dis · 2023-01-01

该大型前瞻性队列研究分析了2000-2017年间459例人类免疫缺陷病毒感染者发生的847次严重细菌性非艾滋病感染,描述了感染类型、细菌学确诊及抗生素耐药演变。研究发现肺炎链球菌作为肺炎和菌血症病原体的比例大幅下降,金黄色葡萄球菌和肺炎链球菌总体耐药性逐渐降低,但肠杆菌科细菌对阿莫西林-克拉维酸、头孢噻肟和环丙沙星的耐药性上升,复方磺胺甲噁唑预防与耐药风险增加相关。

要点

  • 肺炎链球菌作为肺炎和菌血症病原体的比例分别从34%降至8%和从21%降至3%。
  • 肠杆菌科对阿莫西林-克拉维酸耐药从24%升至48%,对头孢噻肟从4%升至18%,对环丙沙星从5%升至27%。
  • 复方磺胺甲噁唑预防与肺炎链球菌对阿莫西林和红霉素非敏感、肠杆菌科对β-内酰胺类和氟喹诺酮类非敏感及产超广谱β-内酰胺酶肠杆菌科风险增高相关。

核心结论

  • 2014至2017年间人类免疫缺陷病毒感染者的细菌耐药模式与普通人群大致相似,但肠杆菌科对氟喹诺酮类的耐药谱更高。
  • 使用复方磺胺甲噁唑作为预防与抗生素耐药风险增加相关。

研究设计与样本

  • 大型前瞻性队列研究,纳入2000至2017年间发生严重细菌性非艾滋病感染且细菌学确诊的人类免疫缺陷病毒感染者。
  • 共459例人类免疫缺陷病毒感染者发生至少1次细菌学确诊的严重细菌性非艾滋病感染,共847次感染。

主要发现

  • 847次感染中,菌血症280例、肺炎269例、尿路感染240例。
  • 分离出1025株细菌,包括肠杆菌科394株(主要为大肠埃希菌)、金黄色葡萄球菌153株、肺炎链球菌82株。
  • 肺炎链球菌作为肺炎病原体的比例从34%降至8%,作为菌血症病原体的比例从21%降至3%。
  • 金黄色葡萄球菌和肺炎链球菌的总体抗生素耐药性逐渐降低,但肠杆菌科耐药性上升:阿莫西林-克拉维酸从24%升至48%,头孢噻肟从4%升至18%,环丙沙星从5%升至27%。
  • 复方磺胺甲噁唑预防与肺炎链球菌对阿莫西林和红霉素非敏感、肠杆菌科对β-内酰胺类和氟喹诺酮类非敏感及产超广谱β-内酰胺酶肠杆菌科风险增高相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe non-AIDS bacterial infections (SBIs) are among the leading causes of hospital admissions among persons with human immunodeficiency virus (PWH) in regions with high antiretroviral therapy coverage. METHODS: This large prospective cohort study of PWH examined the types of infections, bacterial documentation, and evolution of antibiotic resistance among PWH hospitalized with SBIs over an 18-year period. RESULTS: Between 2000 and 2017, 459 PWH had at least 1 SBI with bacterial documentation. Among the 847 SBIs, there were 280 cases of bacteremia, 269 cases of pneumonia, and 240 urinary tract infections. The 1025 isolated bacteria included Enterobacteriaceae (n = 394; mainly Escherichia coli), Staphylococcus aureus (n = 153), and Streptococcus pneumoniae (n = 82). The proportion of S. pneumoniae as the causative agent in pneumonia and bacteremia decreased sharply over time, from 34% to 8% and from 21% to 3%, respectively. The overall antibiotic resistance of S. aureus and S. pneumoniae decreased progressively but it increased for Enterobacteriaceae (from 24% to 48% for amoxicillin-clavulanate, from 4% to 18% for cefotaxime, and from 5% to 27% for ciprofloxacin). Cotrimoxazole prophylaxis was associated with higher nonsusceptibility of S. pneumoniae to amoxicillin and erythromycin, higher nonsusceptibility of Enterobacteriaceae to β-lactams and fluoroquinolones, and a higher risk of extended-spectrum β-lactamase-producing Enterobacteriaceae. CONCLUSIONS: The bacterial resistance pattern among PWH between 2014 and 2017 was broadly similar to that in the general population, with the exception of a higher resistance profile of Enterobacteriaceae to fluoroquinolones. The use of cotrimoxazole as prophylaxis was associated with an increased risk of antibiotic resistance.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Blanc P, Bonnet F, Leleux O, et al. Severe Bacterial Non-AIDS Infections in Persons With Human Immunodeficiency Virus: The Epidemiology and Evolution of Antibiotic Resistance Over an 18-Year Period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine Cohort. Clin Infect Dis. 2023. PMID: 36610063. doi:10.1093/cid/ciac978

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。